3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
4
Glioma
2
Neoplasms
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Brain Neoplasms
1
Interventions
Radiosurgery
33
Radiotherapy
19
Temozolomide
16
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
7
Cyclophosphamide
7
trastuzumab deruxtecan
4
temsirolimus
4
Sunitinib
4
Specimen Handling
4
Mental Status and Dementia Tests
4
motexafin gadolinium
3
fludarabine phosphate
3
fludarabine
3
aldesleukin
3
Trastuzumab
3
Pemetrexed
3
Fluorodeoxyglucose F18
3
Erlotinib Hydrochloride
3
Dexamethasone
3
Capecitabine
3
Bevacizumab
3
pembrolizumab
2
entrectinib
2
efaproxiral
2
Vinorelbine
2
Topotecan
2
Sorafenib
2
Radiotherapy, Intensity-Modulated
2
Quality of Life
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
azeliragon
×
CNS
×
Clear all
NCT05789589
2026-03-04
ADORATION
Baptist Health South Florida
Phase 1/2
Recruiting
46 enrolled